A Case Report of Carbohydrate Antigen 19-9 Producing Advanced Gastric Cancer

Konomi Mizuguchi, Koich Sato, H. Maekawa, M. Sakurada, H. Orita, T. Kushida, K. Senuma, Tomoaki Ito, Hirokazu Matsuzawa, Syunsuke Watanabe, S. Tokuda, S. Ueda, R. Wada
{"title":"A Case Report of Carbohydrate Antigen 19-9 Producing Advanced Gastric Cancer","authors":"Konomi Mizuguchi, Koich Sato, H. Maekawa, M. Sakurada, H. Orita, T. Kushida, K. Senuma, Tomoaki Ito, Hirokazu Matsuzawa, Syunsuke Watanabe, S. Tokuda, S. Ueda, R. Wada","doi":"10.5539/CCO.V5N2P49","DOIUrl":null,"url":null,"abstract":"The gastric cancer producing carbohydrate antigen 19-9 (CA 19-9) is a rare and unknown that characterize informations. 74-year-old woman who was admitted with complaints of epigastric discomfort. An advanced cancer was found in her lower gastric region; biopsy of the tumor revealed poorly-differentiated adenocarcinoma. Her serum CA 19-9 was extremely elevated at 2322 U/ml and computed tomography demonstrated enlargement of the para-aortic lymph node; thus the tumor was considered unresectable. The patient received 8 cycles of chemotherapy with S-1/cisplatin, which shrank the para-aortic lymph node dramatically, hence she underwent D2 gastrectomy. Immunohistochemical staining of the resected cancer revealed that a third of the cancer cells were positive for CA 19-9. In addition, her serum CA 19-9 decreased rapidly after surgery and she remains alive without recurrence three years after surgery. We report one high level of CA 19-9 gastric cancer case with dramatically chemosensitive.","PeriodicalId":89904,"journal":{"name":"Cancer and clinical oncology","volume":"5 1","pages":"49"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5539/CCO.V5N2P49","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer and clinical oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5539/CCO.V5N2P49","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

The gastric cancer producing carbohydrate antigen 19-9 (CA 19-9) is a rare and unknown that characterize informations. 74-year-old woman who was admitted with complaints of epigastric discomfort. An advanced cancer was found in her lower gastric region; biopsy of the tumor revealed poorly-differentiated adenocarcinoma. Her serum CA 19-9 was extremely elevated at 2322 U/ml and computed tomography demonstrated enlargement of the para-aortic lymph node; thus the tumor was considered unresectable. The patient received 8 cycles of chemotherapy with S-1/cisplatin, which shrank the para-aortic lymph node dramatically, hence she underwent D2 gastrectomy. Immunohistochemical staining of the resected cancer revealed that a third of the cancer cells were positive for CA 19-9. In addition, her serum CA 19-9 decreased rapidly after surgery and she remains alive without recurrence three years after surgery. We report one high level of CA 19-9 gastric cancer case with dramatically chemosensitive.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
糖抗原19-9致晚期胃癌1例报告
胃癌产生碳水化合物抗原19-9 (CA 19-9)是一种罕见且未知的特征信息。74岁女性,因上腹不适入院。下胃区发现晚期肿瘤;肿瘤活检显示为低分化腺癌。血清CA 19-9异常升高至2322 U/ml,计算机断层扫描显示主动脉旁淋巴结肿大;因此,肿瘤被认为是不可切除的。患者经S-1/顺铂化疗8周期,主动脉旁淋巴结明显缩小,行D2胃切除术。切除肿瘤的免疫组化染色显示三分之一的癌细胞CA 19-9阳性。此外,术后患者血清CA 19-9迅速下降,术后3年无复发。我们报告一例高水平ca19 -9胃癌患者具有显著的化疗敏感性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Reviewer Acknowledgements for Cancer and Clinical Oncology, Vol. 8, No. 1 Maintenance Metronomic Chemotherapy in Treatment of Metastatic Colorectal Cancer Personal Loss and Grief Experiences of Healthcare Personnel in Pre- and Perinatal Care: A Review of Literature The Changes of Expression Levels in Mir-181a and Mir-30d, and a Significant Correlation between Clinical Patient Data Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy
wanfang
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1